FDA Inspection
Products By O2, IncProducts By O2, Inc – FDA Inspection, Mar 16, 2017
Record Details
This FDA Inspection record concerns Products By O2, Inc, with an inspection on March 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7feeb243-4d68-4b7d-a1fe-b3adcd5b20be
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005899
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 211.186(b)(8)Description of containers, labels, et. al.
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Products By O2, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Products By O2, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.